MedDataX Logo

Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study)

NCT ID: NCT01499927

Last Updated: 2013-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74766 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs, risk of complications as well as higher workload on nursing. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection as Complication of Medical Care

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Early reassessment of intravenous antiinfective therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

electronic reminders

Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders

Group Type ACTIVE_COMPARATOR

electronic reminders

Intervention Type OTHER

Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders

no electronic reminders

Behavioral: Early switching from intravenous to oral antiinfective agents without computerized decision support

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electronic reminders

Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

computerized decision support

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all in-patients in treatment with an intravenous antiinfective for \>60h,
* hospitalized in a ward with computerized physician order entry (cpoe)

Exclusion Criteria

* outpatients,
* ward without cpoe,
* no intravenous antiinfective treatment
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juerg Blaser, Professor

Role: PRINCIPAL_INVESTIGATOR

University Hospital Zurich, Center for Clinical Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Zurich, Center for Clinical Research

Zurich, Canton of Zurich, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Beeler PE, Kuster SP, Eschmann E, Weber R, Blaser J. Earlier switching from intravenous to oral antibiotics owing to electronic reminders. Int J Antimicrob Agents. 2015 Oct;46(4):428-33. doi: 10.1016/j.ijantimicag.2015.06.013. Epub 2015 Jul 21.

Reference Type DERIVED
PMID: 26293470 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FZMI-KEK-ZH-Nr. 2010-0457

Identifier Type: -

Identifier Source: org_study_id